Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/08/2009 | WO2009122443A2 A tumor model system useful to study multistage cancer |
10/08/2009 | WO2009122441A2 Method of cloning stable stress tolerant superoxide dismutase using universal primers |
10/08/2009 | WO2009122401A2 Methods of expressing a polypeptide in the brain and nucleic acid constructs capable of same |
10/08/2009 | WO2009121999A1 Specific promoter of stem cells |
10/08/2009 | WO2009121994A1 Fusion proteins having a beta-trefoil-type lectin domain, method for obtaining same and use thereof |
10/08/2009 | WO2009121804A1 Drug fusions and conjugates |
10/08/2009 | WO2009121536A1 Method of treating genetic disorders |
10/08/2009 | WO2009121208A1 Reagents, chaotropic agents, kits and methods for isolating nucleic acids based on magnetic cellulose materials |
10/08/2009 | WO2009121176A1 Insulin-induced gene (insig) peptide compositions and methods for cytoprotection |
10/08/2009 | WO2009121157A1 Vectors containing the max gene |
10/08/2009 | WO2009102894A3 Arginine-conjugated bioreducible poly (disulfide amine) polymers for gene delivery systems |
10/08/2009 | WO2009102438A3 Aptamer inhibitors of osteopontin and methods of use thereof |
10/08/2009 | WO2009101204A3 Elimination of immune responses to viral vectors |
10/08/2009 | WO2009097351A9 TAK1-D MEDIATED INDUCTION OF CELL DEATH IN HUMAN CANCER CELLS BY SPECIFIC SEQUENCE SHORT DOUBLE STRANDED RNAs |
10/08/2009 | WO2009094772A8 Methods and apparatus for particle introduction and recovery |
10/08/2009 | WO2009094006A3 Bordetella outer-membrane protein antigens and methods of making and using the same |
10/08/2009 | WO2009091904A3 Microrna based methods and compositions for the treatment of cancer |
10/08/2009 | WO2009091720A3 N-linked glycosylation alteration in e1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine |
10/08/2009 | WO2009091659A3 Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant rna agents |
10/08/2009 | WO2009091141A3 Recombinant microorganism having a producing ability of polylactate or its copolymers and method for preparing polylactate or its copolymers using the same |
10/08/2009 | WO2009089399A3 Compositions comprising toll-like receptor or coreceptor antagonists and methods for ocular neuroprotection |
10/08/2009 | WO2009088950A3 Pcv2 orf2 virus like particle with foreign amino acid insertion |
10/08/2009 | WO2009088256A3 Baculovirus-based vaccines |
10/08/2009 | WO2009086116A3 Alternative scaffold protein fusions phage display via fusion to plx of m13 phage |
10/08/2009 | WO2009077611A3 Plants with increased yield and/or increased tolerance to environmental stress (iy-bm) |
10/08/2009 | WO2009068588A3 Transgenic plants with increased stress tolerance and yield |
10/08/2009 | WO2008045148A8 Protease screening methods and proteases identified thereby |
10/08/2009 | WO2001098526A9 Receptor fingerprinting, sensory perception, and biosensors of chemical sensants |
10/08/2009 | WO2001025256A3 Trdl-1-gamma, a novel tumor necrosis-like ligand |
10/08/2009 | US20090255013 Use of virus induced gene silencing (VIGS) to down-regulate gene use in plants |
10/08/2009 | US20090255012 Sweet pepper hybrid 9942595 |
10/08/2009 | US20090255011 Sweet pepper hybrid 9954288 |
10/08/2009 | US20090255010 Tomato hybrid bs 01031842 |
10/08/2009 | US20090255009 Cotton variety fm 9150f |
10/08/2009 | US20090255008 Cotton variety fm 9180b2f |
10/08/2009 | US20090255007 system for production of stable, genetically transformed maize cells; methods of achieving stable transformation include tissue culture methods and media, methods for bombardment of recipient cells with desired transforming DNA, and methods of growing fertile plants from transformed cells |
10/08/2009 | US20090255005 Method for Preparing Fish Embryo |
10/08/2009 | US20090255004 G-Protein Coupled Receptor and Uses Therefor |
10/08/2009 | US20090253952 Methods and Compositions for Improved Fertilization and Embryonic Survival |
10/08/2009 | US20090253902 Isolation of a rearranged human immunoglobulin gene from a chimeric mouse and recombinant production of the encoded immunoglobulin |
10/08/2009 | US20090253897 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
10/08/2009 | US20090253780 COMPOSITIONS AND METHODS RELATED TO miR-16 AND THERAPY OF PROSTATE CANCER |
10/08/2009 | US20090253778 DNA composition against tumor stromal antigen FAP and methods of use thereof |
10/08/2009 | US20090253776 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA |
10/08/2009 | US20090253770 Target gene mimitin of myc |
10/08/2009 | US20090253769 Inhibitors of mammalian hdac 11 useful for treating hdac 11 mediated disorders |
10/08/2009 | US20090253626 50 Human Secreted Proteins |
10/08/2009 | US20090253619 Novel peptide involved in energy homeostasis |
10/08/2009 | US20090253588 Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy |
10/08/2009 | US20090253577 Wheat plants having increased resistance to imidazolinone herbicides |
10/08/2009 | US20090253208 Genetic engineered herpes virus genomes; vaccine; gene transfer into T lymphoid cells comprising infecting a T lymphoid cell with a recombinant herpesvirus |
10/08/2009 | US20090253207 Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells |
10/08/2009 | US20090253206 Nuclear transport agent and method for producing said agent |
10/08/2009 | US20090253205 Thermophilic and thermoacidophilic sugar transporter genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods |
10/08/2009 | US20090253203 Reprogramming a Cell by Inducing a Pluripotent Gene Through Use of a Small Molecule Modulator |
10/08/2009 | US20090253192 Process for the biological production of 1,3-propanediol with high titer |
10/08/2009 | US20090253189 Lactic Acid-Producing Yeast Cells Having Nonfunctional L- or D-Lactate:Ferricytochrome C Oxidoreductase Cells |
10/08/2009 | US20090253185 Avipox recombinants expressing foot and mouth disease virus genes |
10/08/2009 | US20090253184 Compositions and methods related to an adenoviral trans-complementing cell line |
10/08/2009 | US20090253182 Fed-batch fermentation process and culture medium for the production of plasmid dna in e. coli on a manufacturing scale |
10/08/2009 | US20090253179 Permitting the increased production of recombinant proteins; culturing; introducing into the cells agents that inhibit senescence or that promote cell survival |
10/08/2009 | US20090253177 lyases enzymes obtained from transformed plant tissue expressing polynucleotide that encodes the polypeptide; improved ethanol biosynthesis, stalk and nodal strength |
10/08/2009 | US20090253176 Cell lines and methods for producing proteins |
10/08/2009 | US20090253175 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments |
10/08/2009 | US20090253173 Filamentous fungi with inactivated protease genes for altered protein production |
10/08/2009 | US20090253172 Growth factor homolog zvegf4 |
10/08/2009 | US20090253171 Methods For Producing Secreted Polypeptides Having Biological Activity |
10/08/2009 | US20090253169 Use of genetically modified organisms to generate biomass degrading enzymes |
10/08/2009 | US20090253168 improving the membrane permeability of a substrate, hydantoin-transporter activity; obtained by introducing and expressing the novel gene called mhp |
10/08/2009 | US20090253167 Methanol-responsive promoter, fusion gene comprising promoter and foreign gene connected so that foreign gene can be expressed, vector, transformant, and method of producing protein |
10/08/2009 | US20090253164 E. coli for efficient production of caratenoids |
10/08/2009 | US20090253152 NOVEL MUTANT IGFBP-3 MOLECULES THAT DO NOT BIND TO IGFs, BUT RETAIN THEIR ABILITY TO FUNCTIONALLY BIND IGFBP-3 RECEPTOR |
10/08/2009 | US20090253136 Genetic risk assessment technology for epithelial cancer involving gene-environment interaction between ercc5 and tobacco use |
10/08/2009 | US20090253135 POLYMORPHISMS OF THE BLyS GENE AND USE IN DIAGNOSTIC METHODS |
10/08/2009 | US20090253131 Hybrid fusion reporter and uses thereof |
10/08/2009 | US20090253125 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
10/08/2009 | US20090253124 METHOD FOR DETECTING HUMAN PAPILLOMAVIRUS mRNA |
10/08/2009 | US20090252860 Soybean Cultivar 7631014 |
10/08/2009 | US20090252859 Soybean Cultivar 7431014 |
10/08/2009 | US20090252858 Soybean Cultivar 7925084 |
10/08/2009 | US20090252857 Soybean Cultivar 7311153 |
10/08/2009 | US20090252856 Soybean Cultivar S070159 |
10/08/2009 | US20090252828 Alpha-amylase variants with altered properties |
10/08/2009 | US20090252814 Use of xenon for organ protection |
10/08/2009 | US20090252783 Means for inhibiting the expression of cd31 |
10/08/2009 | US20090252766 Attenuated gram negative bacteria |
10/08/2009 | US20090252765 Bacille calmette-guerin (bcg)-based anti-atheroma vaccine and methods of use thereof |
10/08/2009 | US20090252763 Biological adjuvants |
10/08/2009 | US20090252761 Papilloma virus vaccine |
10/08/2009 | US20090252760 Construction of Recombinant Adenovirus With Genes That Codify for SAG1, SAG2 and SAG3 |
10/08/2009 | US20090252755 nucleic acid molecule comprising a hepatitis C virus (HCV) 5' untranslated region (UTR), produces a HCV that infects chimpanzees; for screening assays for the identification of antiviral agents for HCV |
10/08/2009 | US20090252752 Kdr peptides and vaccines comprising the same |
10/08/2009 | US20090252750 Antibodies and immunotoxins that target human glycoprotein nmb |
10/08/2009 | US20090252748 Sp35 Antibodies and Uses Thereof |
10/08/2009 | US20090252747 Immunization; used to elicit a humoral or cellular immune response |
10/08/2009 | US20090252743 Antibody for use in the treatment of crohn's and inflammatory diseases such as ankylosing spondylitis; human tumor necrosis factor alpha (TNF) inhibitors |
10/08/2009 | US20090252737 T Cell Regulatory Genes And Methods Of Use Thereof |
10/08/2009 | US20090252735 Novel Peptides for Development of Diagnostic and Therapeutic Agents and Methods of Using Same |
10/08/2009 | US20090252733 Generation and Profiling of Fully Human Gold-Derived Therapeutic Antibodies Specific for Human CD38 |
10/08/2009 | US20090252729 Single-chain Fc (scFc) regions, binding polypeptides comprising same, and methods related thereto |